Patients with Growth-Related Disorders and Caregivers Prefer the Somapacitan Device to the Somatrogon Device: Results from a Randomized Crossover Study Assessing Device Preference and Ease of Use Following Simulated Injections

Shahid Akhtar,1 Birgitte Berg,2 Johan Medina,3 Maya Nicole Gonczi,4 Sophie Hamilton,5 Emily Hildebrand,4 Nicky Kelepouris,6 Jesper Skov Neergaard,7 Claus Sværke,8 Gitte Ter-Borch,2 Niklas Kahr Rasmussen3 1Devices & Digital Health, Novo Nordisk A/S, Søborg, Denmark; 2Clinical Operations, Obesity, Liv...

Descripció completa

Dades bibliogràfiques

Autors principals:	Akhtar S, Berg B, Medina J, Gonczi MN, Hamilton S, Hildebrand E, Kelepouris N, Neergaard JS, Sværke C, Ter-Borch G, Rasmussen NK
Format:	Artigo
Idioma:	Inglês
Publicat:	Dove Medical Press 2024-10-01
Col·lecció:	Medical Devices: Evidence and Research
Matèries:	growth hormone deficiency long-acting growth hormone device preference ease of use somapacitan somatrogon
Accés en línia:	https://www.dovepress.com/patients-with-growth-related-disorders-and-caregivers-prefer-the-somap-peer-reviewed-fulltext-article-MDER
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!